Cargando…
Evolution of Angiogenic Factors in Pregnant Patients with Breast Cancer Treated with Chemotherapy
SIMPLE SUMMARY: Anthracyclines and taxanes are being used as a standard treatment for breast cancer diagnosed during pregnancy. These chemotherapy regimens allow the continuation of pregnancy without delaying cancer treatment with relatively good maternal and neonatal outcomes. However, their effect...
Autores principales: | Saura, Cristina, Sánchez, Olga, Martínez, Sandra, Domínguez, Carmen, Dienstmann, Rodrigo, Ruíz-Pace, Fiorella, Céspedes, Maria Concepció, Peñuelas, Ángeles, Cortés, Javier, Llurba, Elisa, Córdoba, Octavi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926500/ https://www.ncbi.nlm.nih.gov/pubmed/33672114 http://dx.doi.org/10.3390/cancers13040923 |
Ejemplares similares
-
Cardiac dysfunction and remodeling regulated by anti-angiogenic environment in patients with preeclampsia: the ANGIOCOR prospective cohort study protocol
por: Ullmo, Johana, et al.
Publicado: (2021) -
Impact of Angiogenic and Cardiovascular Biomarkers for Prediction of Placental Dysfunction in the First Trimester of Pregnancy
por: Nan, Madalina Nicoleta, et al.
Publicado: (2023) -
Serum Angiogenic and Anti-angiogenic Markers in Pregnant Women with Placenta Percreta
por: Uyanıkoğlu, Hacer, et al.
Publicado: (2018) -
First-Trimester Sequential Screening for Preeclampsia Using Angiogenic Factors: Study Protocol for a Prospective, Multicenter, Real Clinical Setting Study
por: Trilla, Cristina, et al.
Publicado: (2022) -
Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer
por: Rodriguez-Freixinos, Victor, et al.
Publicado: (2019)